Published in J Reprod Med on November 01, 1995
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet (2007) 7.22
Barriers to contraceptive use in product labeling and practice guidelines. Am J Public Health (2006) 0.93
Human papillomavirus testing in primary cervical screening. Lancet (1995) 5.09
Advising women on which pill to take. BMJ (1995) 4.26
Surgery and the pill. Br Med J (Clin Res Ed) (1985) 3.66
Medical abortion. BMJ (1992) 2.41
Effect of smoking cessation on cervical lesion size. Lancet (1996) 2.35
After Cairo. Br J Obstet Gynaecol (1995) 2.16
Late failure of vasectomy after two documented analyses showing azoospermic semen. Br Med J (Clin Res Ed) (1984) 2.09
The combined oral contraceptive pill: what advice should we give when tablets are missed? Br J Obstet Gynaecol (1995) 2.02
Medical abortion. BMJ (1992) 1.96
Fatherhood without apparent spermatozoa after vasectomy. Lancet (1994) 1.95
Effect of age on pelvic inflammatory disease in nulliparous women using a copper 7 intrauterine contraceptive device. Br Med J (1980) 1.88
Comparative contraceptive efficacy of the female condom and other barrier methods. Fam Plann Perspect (1994) 1.87
Case of ectopic pregnancy after postcoital contraception with ethinyloestradiol-levonorgestrel. Br Med J (Clin Res Ed) (1983) 1.75
A comparative study of the no scalpel and standard incision approaches to vasectomy in 5 countries. The Male Sterilization Investigator Team. J Urol (1999) 1.70
Side effects of danazol compared with an ethinyloestradiol/norgestrel combination when used for postcoital contraception. Contraception (1983) 1.67
Paired cervical smears: a method of reducing the false-negative rate in population screening. Obstet Gynecol (1982) 1.56
Influence of removal of intrauterine contraceptive devices on colonisation of the cervix by actinomyces-like organisms. Contraception (1984) 1.52
Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception. Br J Obstet Gynaecol (1985) 1.44
Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring. Eur J Obstet Gynecol Reprod Biol (1993) 1.43
Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives. BJOG (2000) 1.42
Measuring contraceptive effectiveness: a conceptual framework. Obstet Gynecol (1996) 1.39
Scare over oral contraceptives. If a woman has not had a thrombotic event in years of use she is unlikely to have one now. BMJ (1995) 1.37
Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors. Lancet (1976) 1.24
Complications of vasectomy: review of 16,000 patients. Br J Urol (1984) 1.21
Guidelines for prescribing combined oral contraceptives. BMJ (1996) 1.17
How reliable is a vasectomy? Long-term follow-up of vasectomised men. Lancet (2000) 1.16
Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery. BMJ (1991) 1.11
A comparative study of the safety and efficacy of FemCap, a new vaginal barrier contraceptive, and the Ortho All-Flex diaphragm. The FemCap Investigators' Group. Contraception (1999) 1.10
The safety of intrauterine devices. Stud Fam Plann (1979) 1.08
Hormonal contraception and cancer. Br J Hosp Med (1986) 1.06
Comparison of four cytologic sampling techniques in a large family planning center. Acta Cytol (1993) 1.03
Data support extended use of levonorgestrel intrauterine systems. BMJ (1998) 1.03
Endocrine effects of danazol in menstruating women. J Int Med Res (1977) 1.02
Temporary reappearance of sperm 12 months after vasectomy clearance. Br J Urol (1995) 1.01
A risk-benefit assessment of the levonorgestrel-releasing intrauterine system. Drug Saf (1996) 0.99
Contraception. Br Med J (Clin Res Ed) (1986) 0.97
Very early abortion by prostaglandins. Lancet (1978) 0.96
Letter: IUD and congenital malformation. Br Med J (1976) 0.93
Weak autoantibody reactions to antigens other than sperm after vasectomy. Br Med J (1976) 0.92
The effect of stopping smoking on cervical Langerhans' cells and lymphocytes. BJOG (2001) 0.92
Combined oral contraceptives, migraine and ischaemic stroke. Clinical and Scientific Committee of the Faculty of Family Planning and Reproductive Health Care and the Family Planning Association. Br J Fam Plann (1998) 0.91
Depot medroxyprogesterone acetate and osteoporosis. Monitor serum oestradiol concentration in users. BMJ (1994) 0.91
Gynaecological aspects of the levonorgestrel-releasing intrauterine system. Br J Obstet Gynaecol (1997) 0.91
Behavioural patterns in women requesting postcoital contraception. J Biosoc Sci (1983) 0.88
Clinical applications of fibrinolytic inhibition in gynaecology. J Clin Pathol Suppl (R Coll Pathol) (1980) 0.87
Group B streptococci in women fitted with intrauterine devices. J Clin Pathol (1977) 0.87
Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev (2004) 0.85
Scheme for management of lost IUD threads. IPPF Med Bull (1980) 0.85
Hormonal assessment before and after vasectomy. Br Med J (1976) 0.85
Two randomized controlled trials comparing the tubal ring and filshie clip for tubal sterilization. Fertil Steril (2000) 0.83
Reduction of mefenamic acid of increased menstrual blood loss associated with intrauterine contraception. Br J Obstet Gynaecol (1978) 0.83
Contraceptive effectiveness of two spermicides: a randomized trial. Obstet Gynecol (1999) 0.83
Deaths associated with intrauterine contraceptive devices in the United Kingdom between 1973 and 1983. Br Med J (Clin Res Ed) (1983) 0.83
Do retroverted uteri adversely affect insertions and performance of IUDs? Contraception (1990) 0.82
A study of infant mortality and causes of death in a rural north-east Brazilian community. J Biosoc Sci (1990) 0.82
Experiences and challenges in data monitoring for clinical trials within an international tropical disease research network. Clin Trials (2006) 0.82
The relation between sebum production and plasma 17-oxosteroid levels in normal women and in patients with breast cancer. Eur J Cancer (1972) 0.81
Plasma ferritin levels as an index of iron deficiency in women using intrauterine devices. Br J Obstet Gynaecol (1979) 0.81
Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department. Contraception (1997) 0.81
Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women. Hum Reprod (2005) 0.81
Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide. Contraception (1996) 0.81
Management and treatment of diarrhea in Honduran children: factors associated with mothers' health care behaviors. Soc Sci Med (1992) 0.81
Functional characterization of alpha1-adrenoceptor subtypes in longitudinal and circular muscle of human vas deferens. Eur J Pharmacol (1999) 0.80
A possible mechanism of action of danazol and an ethinylestradiol/norgestrel combination used as postcoital contraceptive agents. Contraception (1986) 0.80
The biochemistry of human endometrium after two regimens of postcoital contraception: a dl-norgestrel/ethinylestradiol combination or danazol. Fertil Steril (1986) 0.79
Randomised comparative study in 217 women of three disposable plastic IUCD thread retrievers. Br J Obstet Gynaecol (1992) 0.78
Contrasting views on human population growth. One wisdom justifies complacency: the other demands action now. BMJ (1999) 0.78
Longer though lighter menstrual and intermenstural bleeding with copper as compared to inert intrauterine devices. Br J Obstet Gynaecol (1978) 0.78
Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over. Br J Haematol (2001) 0.78
Sulpha-trimethoprim combinations and male infertility. Lancet (1978) 0.78
Second trimester pregnancy termination using extra-amniotic ethacridine lactate. Br J Obstet Gynaecol (1990) 0.78
Contraception. BMJ (1991) 0.78
Two hundred out-patient laparoscopic clip sterilizations using local anaesthesia. Br J Obstet Gynaecol (1987) 0.77
A simple scheme for managing the problem of 'lost threads' with intrauterine devices. Fertil Contracept (1979) 0.77
Contraception. Lancet (2000) 0.77
Effect of four combined oral contraceptives on blood pressure in the pill-free interval. Contraception (1993) 0.76
Effect of FTY720 on apoptosis of smooth muscle cells. Transplant Proc (2007) 0.76
Oral contraceptives and the risk of DVT. Practitioner (1996) 0.76
Vasitis nodosa and associated clinical findings. J Clin Pathol (1988) 0.76
Menstrual blood-loss with intrauterine devices. Lancet (1976) 0.76
Natural family planning. Review's enthusiasm based on flawed evidence. BMJ (1993) 0.75
Migraine and stroke in young women. Authors' results suggest that all types of migraine are contraindications to oral contraceptives. BMJ (1999) 0.75
Are there any absolute medical contraindications to the progestogen only oral contraceptive? Br Med J (Clin Res Ed) (1984) 0.75
Pregnancy and labour in the very young (two cases). Proc R Soc Med (1972) 0.75
Venous thromboembolism and oral contraceptives. Lancet (1999) 0.75
Legitimate double think. Lancet (1993) 0.75
Stabilisation of the population is necessary for health for all. BMJ (1997) 0.75
Epidemiology of endometriosis. BMJ (1993) 0.75
Progestogen-only pills (POPs) and body weight. J Fam Plann Reprod Health Care (2001) 0.75
Unintended pregnancies and contraceptive use. BMJ (1991) 0.75
Diagnostic dilatation and curettage. BMJ (1993) 0.75
Population, consumption, and entrapment. Improve access to contraception to curb population growth. BMJ (2000) 0.75
Postpartum contraception. Unnecessary before three weeks. BMJ (1993) 0.75
Stopping the pill. BMJ (1991) 0.75
Hypoglycaemic coma occurring during treatment with chlorpromazine and orphenadrine. Br Med J (1967) 0.75
Intrauterine devices and infertility. Lancet (2001) 0.75
Sickle cell disease and contraception. BMJ (1993) 0.75
Breast cancer and hormone exposure. Lancet (1996) 0.75
Funding international family planning. BMJ (1994) 0.75
Reducing withdrawal bleeds. Lancet (2000) 0.75